The Chemours Company (CC) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.77B |
| Enterprise Value | 5.69B |
| P/E Ratio | -6.74 |
| PEG Ratio | -0.32 |
| Price/Sales Ratio | 0.35 |
| Price/Book Ratio | -41.65 |
| Enterprise/Revenue | 0.94 |
| Enterprise/EBITDA | -32.99 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.05 |
| Operating Margin | -0.05 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -1.7 |
Income Statement
| Revenue | 5.81B |
| Revenue/Share | 38.29 |
| Gross Profit | 902M |
| EBITDA | 332M |
| Net Income | -386M |
| Diluted EPS | -2.56 |
Balance Sheet
| Total Cash | 671M |
| Total Cash/Share | 4.43 |
| Total Debt | 4.12B |
| Total Debt/Equity | -84.08 |
| Current Ratio | 1.66 |
| Book Value Per Share | -0.32 |
Price History
| 52-Week Change | -15.27 |
| 52-Week High | 28.67 |
| 52-Week Low | 10.44 |
| Moving Average 50 Days | 15.5 |
| Moving Average 200 Days | 18.33 |
Statistics
| Average Volume | 2.31M |
| Shares Outstanding | 150.38M |
| % Held by Institutions | 91.73 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.35 |
| Trailing Annual Dividend Yield | 2.6 |
| Payout Ratio | -0.22 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
